Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Astrocytoma × niraparib × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Ovarian Neoplasms 37 Prostatic Neoplasms 11 Breast Neoplasms 10 Fallopian Tube Neoplasms 9 Pancreatic Neoplasms 7 Glioblastoma 6 Neoplasm Metastasis 5 Endometrial Neoplasms 5 Neoplasms 4 Lung Neoplasms 4 Glioma 4 Triple Negative Breast Neoplasms 3 Small Cell Lung Carcinoma 3 Mesothelioma 3 Cholangiocarcinoma 3 Uterine Cervical Neoplasms 2 Squamous Cell Carcinoma of Head and Neck 2 Sarcoma 2 Recurrence 2 Mesothelioma, Malignant 2 Head and Neck Neoplasms 2 Colorectal Neoplasms 2 Carcinoma, Renal Cell 2 Carcinoma, Ovarian Epithelial 2 Brain Neoplasms 2 Biliary Tract Neoplasms 2 Uveal Melanoma 1 Uterine Neoplasms 1 Urothelial Cancer 1 Unilateral Breast Neoplasms 1

Interventions

Temozolomide 58 Radiotherapy 25 Bevacizumab 19 Magnetic Resonance Spectroscopy 16 Irinotecan 15 Carboplatin 13 Filgrastim 12 Carmustine 10 antineoplaston AS 2-1 8 antineoplaston A10 8 Surgical Procedures, Operative 8 sargramostim 7 Radiation 7 Etoposide 7 Vincristine 6 Specimen Handling 6 Radiotherapy, Intensity-Modulated 6 Procarbazine 6 Everolimus 6 Erlotinib Hydrochloride 6 Peripheral Blood Stem Cell Transplantation 5 O(6)-benzylguanine 5 Melphalan 5 Genetic Therapy 5 Cyclophosphamide 5 Aminolevulinic Acid 5 poly ICLC 4 etoposide phosphate 4 Topotecan 4 Thalidomide 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05297864 2025-05-23

OU-SCC-PI-4G

University of Oklahoma

Phase 2 Terminated

15 enrolled 13 charts

Astrocytoma, Glioblastoma, Glioma, Oligodendroglioma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡